Tissium's co-founder and Chief Innovation Officer, Maria Pereira chronicles her journey into medtech and how a plan to mend heart tissue led to the formation of a company. Pereira co-invented Tissium's technology while she was a PhD student at Prof. Jeff Karp’s Laboratories. She has been recognized for her research by MIT Tech Review’s “35 Innovators Under 35” in 2014, as well as Forbes in its “30 under 30” selection in healthcare in 2015.  

EY's Jim Welch stops by to discuss the EY Pulse of the Industry report and to discuss the state of M&A in medtech.

Dr. Jim Mault, BioIntellisense CEO, breaks down the rise of remote patient monitoring and explains why it’s time to drop the term. He also speaks about his time at Microsoft and Qualcomm.

Helmy Eltoukhy, Co-founder and CEO of Guardant Health, dives into the groundbreaking evolution of liquid biopsy, transforming cancer detection. He shares insights about the company's growth and the launch of a new colorectal cancer screening test designed for average-risk individuals. Eltoukhy discusses the pivotal shift from invasive procedures to innovative blood tests and how going public has fueled advancements in their technology. He emphasizes the urgency of early detection and the evolving landscape of medical reimbursement in the diagnostics field.

BIOMEDevice Boston is fully loaded in 2022! Adrienne Zepeda, Group Event Director at Informa Markets - Engineering, gives us the scoop on why this is the show's biggest year ever!

The Massachusetts Medical Device Industry Council (MassMEDIC) has launched the Why Medtech campaign to build awareness of the medical device industry. MassMEDIC's Brian Johnson and Rachel Robinson joins us for this episode to discuss how people can take part in this campaign and why everyone has medtech story.

One of the current trends in the medtech industry involves companies expanding digital solutions. While digital innovation can be slow to progress in regulated industries like healthcare, GE Healthcare is changing the game with Edison Digital Health Platform, a vendor-agnostic hosting and data aggregation platform with an integrated artificial intelligence (AI) engine.  Vignesh Shetty, Senior VP & General Manager of Edison AI And Platform at GE Healthcare, discusses why the digital platform is a difference maker.

Sometimes as a company grows and matures, the corporate identity it started out needs to change. Memic Innovative Surgery is the perfect example as the company has changed its name to Momentis Surgical. In addition the company has also changed the name of its technology from the Hominis Surgical System to Anovo Surgical. DVir Cohen, CEO of Momentis Surgical, discusses the name change and how the Anovo Surgical system stands out in the surgical robotics space.

Ruby Gadelrab, CEO and founder of MDisrupt, stops by Let’s Talk Medtech for a candid conversation about digital health, diversity, and working to create an atmosphere of inclusion in the space. Plus, she shares her professional experience.

It's no secret that Dexcom is on the rise. From commercials during the Super Bowl, to blockbuster products on the horizon, the company is reaching a new height of popularity in the continuous glucose monitoring space. Kevin Sayer, Dexcom CEO, talks about the company's new position the space and all the hype surrounding the upcoming G7 CGM sensor. He also gives his thoughts on where CGM technology is headed in this incredible, can't miss conversation.